about
Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.PRL3-zumab, a first-in-class humanized antibody for cancer therapy.Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.Preclinical vaccines against mammary carcinoma.Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.New Approaches to Difficult Drug Targets: The Phosphatase Story
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Hidden immunotherapy targets challenge dogma
@ast
Hidden immunotherapy targets challenge dogma
@en
type
label
Hidden immunotherapy targets challenge dogma
@ast
Hidden immunotherapy targets challenge dogma
@en
prefLabel
Hidden immunotherapy targets challenge dogma
@ast
Hidden immunotherapy targets challenge dogma
@en
P2860
P1476
Hidden immunotherapy targets challenge dogma
@en
P2093
Soldano Ferrone
P2860
P304
P356
10.1126/SCITRANSLMED.3002821
P407
P577
2011-09-01T00:00:00Z